Related Experiment Video
Updated: Nov 29, 2025

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative
Xiaoxin Zhang1, Yingchun Dong2, Mengxiang Zhao3
1Central Laboratory, Nanjing Stomatological Hospital, Medical School of Nanjing University, 30 Zhongyang Road, Nanjing 210008, China.
Abstract:
Objectives: Integrins, the coordinator of extracellular and intracellular signaling, are often found to be aberrant in tumors and can reshape the tumor microenvironment. Although previous studies showed that integrin beta 2 (ITGB2) is important for host defense, its expression profile and role in tumors, especially in cancer associated fibroblasts (CAFs) are still unknown. Methods: Immunofluorescence stain and fluorescence activated cell sorting were used to analyze the ITGB2 expression profile in oral squamous cell carcinoma (OSCC). RT-PCR and western blot were used to compare ITGB2 expression in normal fibroblasts (NFs) and cancer associated fibroblasts (CAFs). Clinical data and function-based experiments were used to investigate the promoting tumor growth ability of ITGB2 expressing CAFs. Enhanced glycolysis activity was identified by using bioinformatics analyses and GC/MS assays. MCT1 knockdown OSCC cell lines were constructed to explore the pro-proliferative mechanisms of ITGB2 expressing CAFs in multiple in vitro and in vivo assays. Results: We found that CAFs exhibited significantly higher ITGB2 expression than the matched NFs. In addition, higher ITGB2 expression in CAFs was correlated with higher TNM stages and more Ki67+ tumor cells, indicating its ability to promote OSCC proliferation. Further, co-culture assay demonstrated that ITGB2-mediated lactate release in CAFs promoted OSCC cell proliferation. Mechanically, ITGB2 regulated PI3K/AKT/mTOR pathways to enhance glycolysis activity in CAFs. Accordingly, lactate derived from ITGB2-expressing CAFs was absorbed and metabolized in OSCC to generate NADH, which was then oxidized in the mitochondrial oxidative phosphorylation system (OXPHOS) to produce ATP. Notably, inhibiting the OXPHOS system with metformin delayed the proliferative capacity of OSCC cells cultured in the ITGB2-expressing CAFs medium. Conclusions: Our study uncovered the ITGB2high pro-tumoral CAFs that activated the PI3K/AKT/mTOR axis to promote tumor proliferation in OSCC by NADH oxidation in the mitochondrial oxidative phosphorylation system.
Insights
Integrin beta 2 (ITGB2) promotes oral cancer growth by enhancing cancer-associated fibroblast glycolysis and promoting tumor cell oxidative phosphorylation. This study reveals ITGB2 as a potential therapeutic target in oral squamous cell carcinoma.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Integrins are crucial for cell signaling and are often dysregulated in tumors, influencing the tumor microenvironment.
- Integrin beta 2 (ITGB2) is known for its role in host defense, but its function in cancer, particularly within cancer-associated fibroblasts (CAFs), remains unclear.
Purpose of the Study:
- To investigate the expression profile and functional role of ITGB2 in oral squamous cell carcinoma (OSCC).
- To determine the impact of ITGB2 expression in CAFs on OSCC proliferation and identify underlying mechanisms.
Main Methods:
- Analyzed ITGB2 expression in OSCC using immunofluorescence and flow cytometry.
- Compared ITGB2 levels in normal fibroblasts (NFs) and CAFs via RT-PCR and western blot.
- Investigated the pro-tumorigenic effects of ITGB2-expressing CAFs using co-culture assays, metabolic analyses (glycolysis, GC/MS), and *in vitro*/*in vivo* models.
Main Results:
- CAFs showed significantly higher ITGB2 expression than NFs, correlating with advanced TNM stages and increased tumor cell proliferation (Ki67+).
- ITGB2-expressing CAFs promoted OSCC proliferation through enhanced glycolysis and lactate release.
- ITGB2 activated the PI3K/AKT/mTOR pathway in CAFs, increasing glycolysis. OSCC cells utilized this lactate to enhance mitochondrial oxidative phosphorylation (OXPHOS) for ATP production, a process sensitive to metformin.
Conclusions:
- ITGB2-high CAFs act as pro-tumoral agents in OSCC by boosting glycolysis and promoting tumor cell OXPHOS.
- The ITGB2-mediated metabolic reprogramming supports tumor growth and presents a potential therapeutic vulnerability in OSCC.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Other Glycolytic Pathways
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Metabolism
Carbohydrate Catabolism
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

